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1. Introduction
The facial nerve (seventh cranial nerve—CNVII) is the nerve of facial expres-
sion. It innervates all superficial muscles of the face and scalp, the contraction of 
which is responsible for all our numerous facial expressions like anger, pain, fear, 
smile, etc. Facial disfigurement resulting from facial nerve disorders can affect the 
physical, psychological, and emotional integrity of an individual. This might result 
in social, occupational, and educational handicap. The facial nerve is one of the 
most common cranial nerves implicated by disorders. It is a mixed nerve, which 
carries motor, sensory, and parasympathetic fibers. The motor fiber-innervated 
muscles developed from second branchial arch, the sensory fibers transmit the 
special sense of taste, and the parasympathetic fibers supply the submandibular, 
sublingual, and lacrimal glands [1]. Embryologically speaking, it is formed very 
early within the acousticofacial complex from the second branchial arch [2]. Facial 
nerve consists of the juxtaposition of somatic and branchial elements of the cranial 
nerve nuclei, in particular, accounting for trigeminal and facial nerve anastomosis 
[3]. A wide variety of disorders can involve the facial nerve including congenital, 
traumatic, infectious, inflammatory, and neoplastic disorders.
2. Anatomy
The anatomy of the facial nerve is the most complex among other cranial nerves. 
It composed of approximately 10,000 neurons. Seven thousands of these fibers are 
myelinated and innervate the muscles of facial expression and the stapedial muscle. 
The other 3000 nerve fibers form the nervus intermedius with a secretary and 
somatosensory component. These include the afferent taste fiber from the chorda 
tympani nerve, the afferent taste fiber from the soft palate, the parasympathetic 
secretory innervation to sublingual, submandibular and lacrimal glands, and the 
cutaneous sensory component from afferent fibers originating from the skin of the 
auricle and postauricular areas [4]. The brain stem contains the intraaxial segment, 
which consists of the motor nucleus, superior salivary nucleus (parasympathetic), 
and nucleus of tractus solitarius (sensory). On the other hand, the cisternal segment 
consists of the motor root and nervus intermedius (nerve of Wrisberg), which 
emerge from the brain stem and pass into the internal auditory canal. These two 
segments merge at the internal auditory canal to form the canalicular segment. It 
runs in the internal auditory canal between the cochlea and vestibule of the inner 
ear to the geniculate ganglion forming the labyrinthine segment. From the genicu-
late ganglion, three nerves arise, the greater superficial petrosal nerve and lesser 
petrosal nerve carrying the parasympathetic fibers to the lacrimal and parotid gland 
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and the external petrosal nerve supplying the sympathetic fibers to the middle 
meningeal artery. The nerve coursing from the geniculate ganglion to the pyramidal 
eminence forming the tympanic segment. From the pyramidal eminence, it passes 
down to the stylomastoid foramen forming the mastoid segment with branches to the 
stapedius muscle and chorda tympani. The extracranial segment started with emerg-
ing from the stylomastoid foramen, and it runs through the parotid gland giving 
rise to the superior temporozygomatic, inferior cervicofacial, temporal, zygomatic, 
buccal, mandibular, and cervical branches [5] (Figure 1).
Knowledge about the normal anatomy, vascular relationship, and the wide spec-
trum of the abnormalities is vital for the radiologist and neurologist in correctly 
diagnosing and managing facial nerve disorders.
3. Clinical disorders of facial nerve
3.1 Facial palsy
Bell’s palsy is the idiopathic variety of facial nerve palsy where the patient has 
signs and symptoms of paralysis of facial muscles without known etiology. The 
etiologies that should be excluded in diagnosing Bell’s palsy include intracranial 
and extracranial malignancies, infections, trauma, cerebrovascular accident, 
etc. Previously Bell’s palsy was regarded as a diagnosis of exclusion, but in 1984, 
May et al. emphasized that Bell’s palsy is a positive diagnosis based on specific 
clinical features [5]. The clinical features that may help to distinguish it from 
Figure 1. 
The anatomy of the facial nerve. Adopted from the free domain: https://myneurosurg.com/cranial-anatomy/
cranial-nerve-7-facial-nerve-and-its-pathology/.
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other causes of facial palsy include sudden onset of usually unilateral facial palsy 
with the absence of signs and symptoms of CNS, ear, and cerebellopontine angle 
disease. The annual incidence of Bell’s palsy globally is estimated to be 11.5–53.3 
per 100,000 in different population, and generally, the percentage is increasing as 
individuals get older [6–8], although some studies suggest that the highest inci-
dence occurs among young and middle-aged individuals [9]. Bell’s palsy thought 
to account for approximately 60–75% of cases of acute unilateral facial paralysis 
with the right side being affected in 63% of the time. It can also be recurrent 
with a reported recurrence range of 4–14% [10]. It affects both sexes equally but 
might affect women more than men in a certain age group. The lowest incidence is 
reported in persons younger than 10 years, and the highest incidence is in a person 
aged 70 years or older. Rarely it might occur bilaterally (0.3%), and positive family 
history is found in 4–14% of patients [11].
The pathophysiology of Bell’s palsy remains unclear. Compression of the facial 
nerve while it course through facial canal, especially the narrow labyrinthine 
segment, is the most acceptable theory. The compression has been demonstrated in 
MRI scan with facial nerve enhancement [12]. Any inflammatory, demyelinating, 
and ischemic or compressive process in this area may impair the neural conduc-
tion. Viral infection is the most commonly accepted theory behind Bell’s palsy, and 
the Herpes simplex virus is the most commonly implicated virus. Other viruses 
include Mumps virus, cytomegalovirus, and HIV. Other suggested theories include 
autoimmunity, mycoplasma infection, inflammation, microvascular disease such 
as diabetes mellitus, and many other mechanisms. It is apparent that none of these 
theories stands on a solid base.
Bell’s palsy typically occurs suddenly, and the symptoms peak in less than 
48 hours. The paralysis must include the upper and lower aspects of the face, oth-
erwise, if it involves the lower portion of the face, a central cause (supranuclear), 
such as stroke, should be suspected. If the onset of the facial paralysis is insidious, 
associated with weakness of the contralateral side, or there is a preceding history of 
trauma or infection, other causes of facial paralysis must be strongly considered.
In addition to the sudden onset of unilateral upper and lower facial muscle paraly-
sis, the patient may have hyperacusis, posterior auricular pain, otalgia, incomplete eye 
closure, excessive salivation, and taste disturbances. Many patients report numbness 
on the affected side. Whether this numbness is due to the involvement of trigeminal 
nerve or lack of movement of facial muscle is not clear. Ocular pain, epiphora or 
decreased tearing, and blurred vision are other possible associated symptoms.
On examination, in addition to demonstrate weakness and/or paralysis of the 
entire side of the face, we find a flattening of the nasolabial fold on the affected 
side, inability to elevate eyebrow, and distorted face when the patient asked to smile 
(Figure 2). The patient should be examined in details for full neurological examina-
tion, any skin lesion, ear or eye problem, and parotid diseases.
The goal of treatment of Bell’s palsy is to improve the facial nerve function and 
to reduce neuronal damage. Steroids (prednisone) and antiviral therapy (acyclovir) 
are the recommended therapy by the American Academy of Neurology (AAN) 
and American Academy of Otolaryngology [13]. Additionally, a variety of non- 
pharmacological therapy is suggested for the treatment of Bell’s palsy including 
physical therapy (facial exercises, neuromuscular training) and acupuncture. A 
variety of pharmacological and non-pharmacological treatments to protect the eyes 
of patient with Bell’s palsy have been used. These include the use of topical ocular 
lubrication (with artificial tear during the day and lubricating ophthalmic ointment 
at night), occluding the eyelids by tape or patch, inducing ptosis by botulinum 
toxins, and many other procedures aiming to protect the patient’s eye from drying, 
corneal abrasion, and corneal ulcers [14, 15].
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Surgical treatment of Bell’s palsy with facial nerve decompression is also used, 
but it still carries a controversy, and it may be considered in patients with poor 
prognosis as predicted by facial nerve testing (EMG shows greater than 90% axonal 
degeneration within 3 weeks of the onset of paralysis) or complete persistent 
paralysis not responding to treatment [16, 17].
Other possible causes of facial palsy include congenital facial palsy (Möbius syn-
drome, hemifacial macrosomia), polyneuritis (Guillain-Barre syndrome, Ramsay-
Hunt syndrome due to herpes zoster, autoimmune) malignancy (parotid tumors, 
brain tumor), trauma (temporal bone fracture, birth injury), sarcoidosis, infections 
(otitis media, cholesteatoma), and many other rare causes [18].
3.2 Tumors
Facial nerve tumors are rare and represent uncommon cause for facial 
palsy accounting for only 5–10% of all cases of facial nerve palsy [19]. Hearing 
defects and facial paresis are the most common presenting features. The most 
commonly identified tumor are schwannomas. Facial nerve schwannomas are 
benign tumors, which arise from Schwann cells. They mostly occur sporadically; 
some occur as a part of genetic syndromes as neurofibromatosis types 1 and 2. 
The facial nerve is the third common site for intracranial schwannomas. The 
patient usually presents with sudden onset or progressive facial weakness with or 
without conductive or sensorineural hearing loss, tinnitus, vertigo, facial pain, 
hemifacial spasm, facial palsy, and otalgia. Workup may involve detailed hearing 
test, MRI scan of the brain, and CT scan of the temporal bone. Other tumors 
involving the facial nerve include hemangiomas (accounting for 18% of facial 
nerve tumors and 0.7% of intratemporal bone tumors) [20], neurofibromas, and 
meningiomas. Most of these tumors present with facial palsy with or without 
hearing defects.
Figure 2. 
Seven-year-old child with left facial palsy asked to smile (published with parent permission).
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3.3 Hemifacial spasm (HFS)
It is a segmental myoclonus of muscles innervated by the facial nerve. Gowers 
first described it in 1884. It affects 11 per 100,000 of the population mostly in the 
fifth and sixth decade of life with a slight female predominance. The majority of 
cases are unilateral, although bilateral involvement might occur rarely in severe 
cases. It generally starts as brief clonic movements of the orbicularis oculi that 
spread over the years to other facial muscles (corrugator, frontalis, orbicularis 
oris, platysma, and zygomaticus), and it may become more sustained with time. 
Although it is a benign condition, it often leads to social embarrassment resulting 
in psychosocial stress and social withdrawal (Figure 3). HFS is characterized by 
progressive involuntary clonic or tonic movements of the muscle supplied by the 
facial nerve. It typically started in the orbicularis oculi muscle and progressively 
extends to involve the other facial muscle, involving the platysma muscle in severe 
cases. Most of the cases persist during sleep, and some patients report clicking 
sound in the ear, which presumed to be due to contraction of the stapedius muscle. 
In severe cases, impairment of vision might occur because of severe spasm of the 
orbicularis oculi muscle. The symptoms are usually exaggerated by psychological 
tension and speech. The main differential diagnosis of HFS includes blepharospasm 
(occur bilaterally symmetrically), oromandibular dystonia (sustained contraction 
of the lower part of the face, mouth, mandible and maxilla, tongue and pharynx), 
facial nerve tic (complex coordinated multifocal movement that switches between 
the right and left sides of the face), hemimasticatory spasm (painful contractions 
of the muscles of mastication), focal seizures, and synkinesias after facial nerve 
paralysis (activation of several muscles innervated by the facial nerve).
The underlying cause of hemifacial spasm in most cases is an ectatic or atypi-
cally aberrant blood vessel, which compresses the facial nerve at the place where 
it exits the brain stem. This area is the most susceptible part of the facial nerve to 
external stimuli since it ensheathed only by an arachnoidal membrane without the 
epineurium. Furthermore, this area represents the transition zone between central 
(oligodendroglial cells) and peripheral (Schwann cells) myelinations, and there is 
no connective tissue septa that traverse the individual fascicles. In the majority of 
cases, inferior posterior cerebellar artery or the inferior anterior cerebellar artery is 
the cause for vascular compression. Rarely, vertebral artery or a combination of these 
arteries is responsible for this compression. Very rarely, a vein might be the cause. HFS 
diagnosis is mainly clinically supported by investigations such as electromyography 
(EMG) and MRI. These investigations are useful also to exclude pathological changes 
in the cerebellopontine angle such as tumors or brain stem lesions. A high-resolution, 
T2-weighted sequence is particularly useful in demonstrating vascular compression.
Figure 3. 
The editor of this book is afflicted by right-sided HFS started at the age of 45; unfortunately, vascular 
decompression failed to resolve the problem. (A) Spasm of the right orbicularis oculi and right facial muscle 
and (B) spontaneous resolution of the spasm.
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The therapeutic options for HFS are variable ranging from simple applications 
of heat to pharmacological treatment (carbamazepine, clonazepam, baclofen, and 
gabapentin) and botulinum injections to microvascular decompression surgery. The 
response to medications, in general, is poor and not sustained and thus is devoted to 
milder cases. Botulinum toxin (BOTOX, BTX) became the standard treatment since its 
use in the early 1980s. It alleviates symptoms in 85–95% of patients. The major draw-
back is its temporary effects and the need to repeat its administration every 3–4 months 
[21–23]. The major advantages of BTX are that it is a noninvasive technique and can 
be done in an outpatient setting. The only curative therapeutic option is microvascular 
decompression of the facial nerve by placing a Teflon sponge between the vessel and 
the brain stem. Using an endoscopic technique makes the operation safe, but still, 
there is a risk of less than 1% of intraoperative life-threatening complications such 
as life-threatening hemorrhage or cerebellar or brain stem infarctions. Additionally, 
postoperative complications including temporary or permanent hearing impairment 
and permanent facial paralysis may occur in up to 8 and 0.9%, respectively [24].
3.4 Blepharospasm
It is the idiopathic progressive bilateral involuntary spasm of the orbicularis 
oculi and upper facial muscle (Figure 4). Involvement of the lower face by spasm 
is not uncommon, and the patient might be functionally blind as the eyes might be 
closed most of the day. The cause of the blepharospasm is thought to be central, yet 
the exact mechanism is not known. Treatment options include selective destruc-
tion of facial nerve branches that innervate the orbicularis oculi muscle, inducing 
paralysis of orbicularis oculi muscle by BOTOX, and pharmacological therapy by 
anticholinergics drug (Artane), benzodiazepine (clonazepam), GABAB receptor 
agonist (baclofen), anticonvulsant (levetiracetam), and many other drugs [25].
4. Investigations
In addition to a detailed history and clinical examination, investigations are an 
essential part of the workup of patients with facial nerve disorders. Still, there are 
controversies about the appropriate investigations that are needed for patients pres-
ent with facial nerve disorders. The most commonly used investigations include:
4.1 Audiometry and brain stem auditory evoked response
These tests used to detect any associated hearing defect and diminished stapedial 
reflex (paresis of the stapedial branch of the facial nerve). Brain stem auditory evoked 
response (BAER) in particular is effective in detecting retrocochlear lesion. These 
tests are not used routinely unless there are multiple cranial nerve palsies [26, 27].
Figure 4. 
(A) Patient with blepharospasm and (B) same patient after treatment.
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4.2 Full blood count
Facial paralysis is a recognized feature of leukemia relapses in both children 
and adult.
4.3 Imaging studies
Imaging studies play an important role in the evaluation of facial nerve disorder. 
MRI is especially helpful in recognizing brain stem pathology, and high-resolution 
CT scan is helpful in identifying bony abnormalities of the intratemporal facial 
nerve like congenital anomalies, trauma, and cholesteatoma. MRI is especially help-
ful in the detection of soft tissue abnormalities around facial nerve as in neoplasms, 
inflammatory processes, and hemifacial spasm. Recently, facial nerve ultrasound 
and diffuse tensor tractography (three-dimensional reconstruction of facial nerve 
using MRI) are used to identify cranial nerve fiber displacement by vestibular 
schwannomas [28, 29]. Contrast-enhanced MRI is helpful when the facial palsy 
cannot be definitively localized [30]. The patient’s symptoms and the proposed 
differential diagnosis will determine the choice between these investigations.
4.4 Neurophysiological studies
Neurophysiological studies are of diagnostic and prognostic value, especially in 
chronic facial nerve problem. Most of these tests require the cooperation of patients. 
Examples of these tests include measurement of fibrillation potentials and recording 
of the blink reflex. The presence of fibrillation potentials, which is part of the elec-
tromyography, in the muscles implies the loss of muscle innervation, which indicates 
a significant axonal degeneration. Blink reflex tests, on the other hand, utilize the 
polysynaptic nature of this reflex. Trigeminal nerve carries a unilateral stimuli 
(electric stimulation of the supraorbital nerve or a puff of air on the cornea), pro-
ducing an early ipsilateral facial motor response followed by a bilateral late response. 
Absence or delay in the late response can be used to assess facial innervation [31].
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